Nuo Therapeutics (AURX) Stock Statistics & Valuation Metrics

Nuo Therapeutics has a market cap or net worth of $74.02M. The enterprise value is $65.64M.

Nuo Therapeutics has 46,823,180 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nuo Therapeutics’s return on equity (ROE) is -4.52 and return on invested capital (ROIC) is -362.56%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Nuo Therapeutics had revenue of 1.37M and earned -2.32M in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was -1.67M and capital expenditures -384.85K, giving a free cash flow of -2.05M billion.

Nuo Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Nuo Therapeutics upcoming earnings date is Aug 8, 2022, TBA (Confirmed).

Nuo Therapeutics as a current ratio of 1.45, with Debt / Equity ratio of -69.51%

In the past 12 months, Nuo Therapeutics has paid 0.00 in taxes.

Nuo Therapeutics EV to EBITDA ratio is -26.88, with an EV/FCF ratio of -26.60.

Nuo Therapeutics has $55.66K in cash and marketable securities with $148.11K in debt, giving a net cash position of $92.45K billion.

Gross margin is 76.89%, with operating margin of -180.04%, and net profit margin of -170.21%.

The average price target for Nuo Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―